Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c583eabbaa4ab08322002fba3d3b2f70 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
1999-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79e688b78ebe06a790182683f02f4534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a15e63236e27873e104d58c985ec71f |
publicationDate |
2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2527410-T3 |
titleOfInvention |
Myostatin immunoconjugates for the treatment of progressive muscle atrophy |
abstract |
Use of a composition comprising a myostatin immunoconjugate for the preparation of a medicament for treating progressive muscle atrophy in a mammal, wherein the immunoconjugate comprises a transporter fused to a myostatin multimer, in which the transporter stimulates cell activity Cooperative T's, and wherein the myostatin multimer has the general formula (MP-XMP) and, wherein each MP is independently selected from the group consisting of a) amino acids 3-15 of SEQ ID NO: 6; b) amino acids 3-17 of SEQ ID NO: 8; c) amino acids 3-16 of SEQ ID NO: 10; d) amino acids 3-22 of SEQ ID NO: 16; e) amino acids 3-19 of SEQ ID NO: 8; f) amino acids 3-18 of SEQ ID NO: 20; and g) amino acids 3-18 of SEQ ID NO: 22, X is selected from the group consisting of: a peptide bond; an amino acid spacer group; and [MP] n, where n is greater than or equal to 1; y in which y is greater than or equal to 1 |
priorityDate |
1998-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |